Janssen Biotech, Inc. Drug Patent Portfolio
Janssen Biotech, Inc. owns 1 purple book drug protected by 6 US patents Given below is the list of Janssen Biotech, Inc.'s drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10961307 | Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody | 24 Sep, 2039 | Active |
| US9217168 | Methods of cell culture | 14 Mar, 2033 | Active |
| US9663810 | Methods of cell culture | 14 Mar, 2033 | Active |
| US8852889 | Cell culture process | 06 Jul, 2032 | Active |
| US9475858 | Cell culture process | 06 Jul, 2032 | Active |
| US6902734 | Anti-IL-12 antibodies and compositions thereof | 25 Sep, 2023 | Active |
Janssen Biotech, Inc.'s Family Patents
Janssen Biotech, Inc. Drug List
Given below is the complete list of Janssen Biotech, Inc.'s drugs and the patents protecting them.
1. Stelara
Stelara is protected by 6 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10961307 | Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody |
24 Sep, 2039
(14 years from now)
| Active |
| US9217168 | Methods of cell culture |
14 Mar, 2033
(8 years from now)
| Active |
| US9663810 | Methods of cell culture |
14 Mar, 2033
(8 years from now)
| Active |
| US8852889 | Cell culture process |
06 Jul, 2032
(7 years from now)
| Active |
| US9475858 | Cell culture process |
06 Jul, 2032
(7 years from now)
| Active |
| US6902734 | Anti-IL-12 antibodies and compositions thereof |
25 Sep, 2023
(1 year, 1 month ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stelara's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List